“Panel Discussion: Treatment Options for Relapsed Refractory Diffuse Large B-Cell Lymphoma (R R DLBCL) Patients”. Canadian Hematology Today 1, no. S10 (October 30, 2022). Accessed June 22, 2026. https://canadianhematologytoday.com/article/view/29.